Percutaneous Mitral Valve Repair: Potential in Heart Failure Management

摘要: As a large portion of the US demographic advances into later decades life, incidence valvular heart disease is expected to increase. Mitral regurgitation (MR) caused by primary valve abnormality (degenerative) or secondary cardiomyopathy (functional) an important cause failure. Management account for segment services provided failure patients. Recent years have seen transition from surgical therapy minimally invasive techniques, specifically percutaneous approaches correction disease. The double orifice technique mitral repair using MitraClip™ System (Abbott Vascular, Menlo Park, CA) one many treat significant MR. This effective in patients with both degenerative and functional MR, reducing MR severity improving symptoms. Broad acceptance this technology requires collaboration among cardiologists cardiac surgeons centers superior catheter experience knowledge echocardiography.